Research location
Érd
Hungary
Advertisement
Research activity in Érd
HungaryCureCurrent currently publishes aggregate city-level research activity for this location: 32 trials and 32 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Érd
32 linked trials · page 1 of 1A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary CareNCT02807857 · 2016-07-07 · 1 site observation
COMPLETED
TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)NCT02676089 · 2016-04-06 · 1 site observation
COMPLETED
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With AsthmaNCT02224157 · 2014-11-28 · 1 site observation
COMPLETED
Phenotypes of COPD in Central and Eastern EuropeNCT02119494 · 2014-06-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent AsthmaNCT02031640 · 2013-12-01 · 1 site observation
COMPLETED
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsNCT01576718 · 2012-04-01 · 1 site observation
COMPLETED
Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in HungaryNCT01534936 · 2012-02-01 · 1 site observation
COMPLETED
ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical PracticeNCT01388166 · 2011-09-01 · 1 site observation
COMPLETED
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)NCT01329029 · 2011-05-01 · 1 site observation
COMPLETED
Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus GlimepirideNCT01233622 · 2010-10-01 · 1 site observation
COMPLETED
Seroquel XR in the Long Term Treatment of SchizophreniaNCT01202617 · 2010-09-01 · 1 site observation
COMPLETED
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseNCT01126437 · 2010-05-01 · 1 site observation
COMPLETED
A Study to Assess the Long-term Safety of QVA149NCT01120717 · 2010-04-01 · 1 site observation
COMPLETED
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on MetforminNCT01006603 · 2009-10-01 · 1 site observation
COMPLETED
Seroquel XR in Schizophrenia Relapse PreventionNCT00990626 · 2009-10-01 · 1 site observation
COMPLETED
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)NCT00902369 · 2009-05-01 · 1 site observation
COMPLETED
Asthma Control and Clinical Practice in Hungary 2009NCT00900861 · 2009-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseNCT00877383 · 2009-04-01 · 1 site observation
COMPLETED
A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIALNCT00801853 · 2009-03-01 · 1 site observation
COMPLETED
Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex TherapyNCT00692874 · 2008-06-01 · 1 site observation
COMPLETED
Tiotropium/Salmeterol Inhalation Powder in COPDNCT00668772 · 2008-04-15 · 1 site observation
TERMINATED
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.NCT00563381 · 2008-01-01 · 1 site observation
COMPLETED
A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent AsthmaNCT00545272 · 2007-10-01 · 1 site observation
COMPLETED
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.NCT00528996 · 2007-09-06 · 1 site observation
COMPLETED
An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible AsthmaNCT00563056 · 2007-09-01 · 1 site observation
COMPLETED
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)NCT00500331 · 2007-01-23 · 1 site observation
COMPLETED
Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)NCT00424268 · 2007-01-01 · 1 site observation
COMPLETED
Tiotropium / Respimat One Year Study in COPD.NCT00387088 · 2006-09-01 · 1 site observation
COMPLETED
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00327015 · 2006-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)NCT00163436 · 2005-09-01 · 1 site observation
COMPLETED
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDNCT00206167 · 2005-04-01 · 1 site observation
COMPLETED
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD PatientsNCT00144339 · 2002-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.